January 18, 2019 Texas HIV Medication Advisory Committee
»
1. Call to Order - Philip Keiser, M.D., Chair
1. Call to Order - Philip Keiser, M.D., Chair
»
2. Welcome and Introductions - Philip Keiser, M.D., Chair
2. Welcome and Introductions - Philip Keiser, M.D., Chair
»
3. Approval of previous meeting minutes (October 26, 2018) - Philip Keiser, M.D. and Committee
3. Approval of previous meeting minutes (October 26, 2018) - Philip Keiser, M.D. and Committee
»
4. Discussion Item- Meeting of Governance and Data Subcommittee - Philip Keiser, M.D., Chair
4. Discussion Item- Meeting of Governance and Data Subcommittee - Philip Keiser, M.D., Chair
»
5. Discussion Item-Formation and Structure of Subcommittees
5. Discussion Item-Formation and Structure of Subcommittees
»
6. Action Item - Request from Merck & Co., Inc. for recommendation to add Delstrigo to the THMP formulary- Philip Keiser, M.D., Chair
6. Action Item - Request from Merck & Co., Inc. for recommendation to add Delstrigo to the THMP formulary- Philip Keiser, M.D., Chair
»
7. Action Item - Request from Merck & Co., Inc. for recommendation to add Pifeltro to the THMP formulary- Philip Keiser, M.D., Chair
7. Action Item - Request from Merck & Co., Inc. for recommendation to add Pifeltro to the THMP formulary- Philip Keiser, M.D., Chair
»
Items 8 & 9 » - 8. Schedule next meeting/Public Comment - Philip Keiser, M.D., Chair 9. Adjourn - Philip Keiser, M.D., Chair
Items 8 & 9 »
8. Schedule next meeting/Public Comment - Philip Keiser, M.D., Chair 9. Adjourn - Philip Keiser, M.D., Chair
